Yttrium Plate
High Purity Y
Plate
CAS 7440-65-5
| CHEMICAL IDENTIFIER |
Formula | CAS No. | PubChem SID | PubChem CID | MDL No. | EC No | Beilstein Re. No. |
SMILES Identifier |
InChI Identifier |
InChI Key |
|---|---|---|---|---|---|---|---|---|---|---|
| Y | 7440-65-5 | 24855941 | 23993 | MFCD00011468 | 231-174-8 | N/A | [Y] | InChI=1S/Y | VWQVUPCCIRVNHF-UHFFFAOYSA-N |
| PROPERTIES | Mol. Wt. | Appearance | Density | Tensile Strength | Melting Point | Boiling Point | Thermal Conductivity | Electrical Resistivity | Eletronegativity | Specific Heat | Heat of Vaporization | Heat of Fusion | MSDS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.91 | Silvery | 4472 kg/m³ | 67 MPa | 1526 °C | 3336 °C | 0.172 W/cm/K @ 298.2 K | 57.0 microhm-cm @ °C | 1.3 Paulings | 0.068 Cal/g/K @ 25 °C | 93 K-Cal/gm atom at 3338 °C | 4.10 Cal/gm mole | Safety Data Sheet |
See research below. American Elements specializes in producing Yttrium as plates in various thicknesses and sizes. Most plates are cast for use in coating and thin film Chemical Vapor Deposition (CVD) and Physical Vapor Deposition (PVD) processes including Thermal and Electron Beam (E-Beam) Evaporation, Low Temperature Organic Evaporation, Atomic Layer Deposition (ALD), Organometallic and Chemical Vapor Deposition (MOCVD) for specific applications such as fuel cells and solar energy. Thicknesses start at 0.25" for all metals. Materials are produced using crystallization, solid state and other ultra high purification processes such as sublimation. American Elements specializes in producing custom compositions for commercial and research applications and for new proprietary technologies. American Elements also casts any of the rare earth metals and most other advanced materials into rod, bar or plate form, as well as other machined shapes and through other processes such as nanoparticles (See also application discussion at Nanotechnology Information and at Quantum Dots) and in the form of solutions and organometallics. We also produce Yttrium as rods, powder and plates. Other shapes are available by request.
Yttrium is a Block D, Group 3, Period 5 element. The number of electrons in each of Yttrium's shells is 2, 8, 18, 9, 2 and its electronic configuration is [Kr] 4d1 5s2. In its elemental form Yttrium's CAS number is 7440-65-5. The yttrium atom has a radius of 177.6.pm and it's Van der Waals radius is 200.pm. Insoluble compounds of Yttrium are non-toxic, although water soluble compounds are somewhat toxic. Yttrium has the highest thermo-dynamic affinity for oxygen of any element. This characteristic is the basis for many of its applications. Yttrium is not found in nature as a free element and is almost always found combined with the lanthanides in rare earth minerals. While not part of the rare earth series, it resembles the heavy rare earths which are sometimes referred to as the "yttrics" for this reason. Another unique characteristic derives from its ability to form crystals with useful properties. Yttrium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra high purity); metals in the form of foil, sputtering target, and rod, and compounds as
submicron and nanopowder. Some of the many applications of yttrium include in ceramics for crucibles for molten reactive metals, in florescent lighting phosphors, computer displays and automotive fuel consumption sensors.Yttria stabilized
zirconium oxide are used in high temperature applications, such as in thermal plasma sprays to protect aerospace high temperature surfaces and as an electrolyte in solid oxide fuel cells. Argonne National Laboratory researchers recently discovered that Yttrium Oxide (Y2O3) in nanometer-sized particles undergoes a definite phase transition under pressure that results in characteristics quite different from bulk Yttrium Oxide (Y2O3). This finding has important implications for the use of Yttrium Oxide as a nanomaterial. The name Yttrium originated from a Swedish village near Vaxholm called Yttbery where Yttrium was discovered. Crystals of the yttrium-iron-garnet (YIG) variety are essential to microwave communication equipment. The phosphor Eu:Y2O2S creates the red color in televisions. Crystals of the yttrium-aluminum-garnet (YAG) variety are utilized with neodymium in a number of laser applications. Yttria can also increase the strength of metallic alloys. Yttrium was first discovered by Johann Gadolin in 1794. See Yttrium research below.
HEALTH, SAFETY & TRANSPORTATION INFORMATION |
|||||
|---|---|---|---|---|---|
N/A |
|||||
N/A |
|||||
N/A |
|||||
N/A |
|||||
N/A |
|||||
ZG2980000 |
|||||
N/A |
|||||
3 |
|||||
| N/A | |||||
PACKAGING SPECIFICATIONS FOR BULK & RESEARCH QUANTITIES |
|---|
| Typical bulk packaging includes palletized plastic 5 gallon/25 kg. pails, fiber and steel drums to 1 ton super sacks in full container (FCL) or truck load (T/L) quantities. Research and sample quantities and hygroscopic, oxidizing or other air sensitive materials may be packaged under argon or vacuum. Shipping documentation includes a Certificate of Analysis and Material Safety Data Sheet (MSDS). Solutions are packaged in polypropylene, plastic or glass jars up to palletized 440 gallon liquid totes. |
|
|
Recent Research & Development for Yttrium
- Comparison of the effect of hand instruments, an ultrasonic scaler, and an erbium-doped yttrium aluminium garnet laser on root surface roughness of teeth with periodontitis: a profilometer study. Amid R, Kadkhodazadeh M, Fekrazad R, Hajizadeh F, Ghafoori A. J Periodontal Implant Sci. 2013 Apr;43(2):101-5. doi: 10.5051/jpis.2013.43.2.101.
- Structure and dynamics in yttrium-based molten rare earth alkali fluorides. Levesque M, Sarou-Kanian V, Salanne M, Gobet M, Groult H, Bessada C, Madden PA, Rollet AL. J Chem Phys. 2013 May 14;138(18):184503. doi: 10.1063/1.4802986.
- Proton trapping in yttrium-doped barium zirconate. Yamazaki Y, Blanc F, Okuyama Y, Buannic L, Lucio-Vega JC, Grey CP, Haile SM. Nat Mater. 2013 May 12. doi: 10.1038/nmat3638.
- Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease. Turkmen C, Ucar A, Poyanli A, Vatankulu B, Ozkan G, Basaran M, Serin K, Sanli Y, Adalet I. Cancer Biother Radiopharm. 2013 May 6.
- Preparation and characterization of nanodispersions of yttria, yttrium aluminium garnet and lutetium aluminium garnet. Bredol M, Micior J. J Colloid Interface Sci. 2013 Apr 12. doi:pii: S0021-9797(13)00318-4. 10.1016/j.jcis.2013.03.060.
- A phase i trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-hodgkin lymphoma. Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ. Am J Hematol. 2013 Apr 26. doi: 10.1002/ajh.23460.
- Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. Lau WY, Sangro B, Chen PJ, Cheng SQ, Chow P, Lee RC, Leung T, Han KH, Poon RT. Oncology. 2013;84(5):311-8. doi: 10.1159/000348325.
- Treatment of urethral/bladder neck stricture after high-intensity focused ultrasound for prostate cancer with holmium: yttrium-aluminium-garnet laser. Cho WJ, Kim TH, Lee HS, Chung JW, Lee HN, Lee KS. Int Neurourol J. 2013 Mar;17(1):24-9. doi: 10.5213/inj.2013.17.1.24.
- Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis. Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ. J Vasc Interv Radiol. 2013 Apr 18. doi:pii: S1051-0443(13)00719-7. 10.1016/j.jvir.2013.02.031.
- Growth and characterization of a novel nonlinear optical borate crystal - Yttrium calcium borate (YCB). Arun Kumar R, Arivanandhan M, Dhanasekaran R, Hayakawa Y. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Jun;110:391-4. doi: 10.1016/j.saa.2013.03.069.
- Prospective Comparison of Hydrogel-coated Microcoils Versus Fibered Platinum Microcoils in the Prophylactic Embolization of the Gastroduodenal Artery before Yttrium-90 Radioembolization. Maleux G, Deroose C, Fieuws S, Van Cutsem E, Heye S, Bosmans H, Verslype C. J Vasc Interv Radiol. 2013 Apr 9. doi:pii: S1051-0443(13)00604-0. 10.1016/j.jvir.2013.01.503.
- Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after a new induction regimen in intermediate and high-risk follicular lymphoma patients according to the follicular lymphoma international prognostic index (FLIPI): A multicenter, prospective Phase II trial of Spanish Lymphoma Oncology Group. Provencio M, Cruz Mora MA, Gómez Codina J, Quero Blanco C, Llanos M, García Arroyo FR, De la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; On behalf of the GOTEL (Spanish Lymphoma Oncology Group). Leuk Lymphoma. 2013 Apr 11.
- Basophilic Round Bodies in Gastritic Biopsies Little Known by Pathologists: Iatrogenic Yttrium 90 Microspheres Deriving From Selective Internal Radiation Therapy. Luo DL, Chan JK. Int J Surg Pathol. 2013 Apr 17.
- Single-Treatment Resolution of Vascular Blebs Within Port Wine Stains Using a Novel 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser. Brauer JA, Geronemus RG. Dermatol Surg. 2013 Apr 5. doi: 10.1111/dsu.12207.
- Evaluation of magnesium-yttrium alloy as an extraluminal tracheal stent. Luffy SA, Chou DT, Waterman J, Wearden PD, Kumta PN, Gilbert TW. J Biomed Mater Res A. 2013 Mar 29. doi: 10.1002/jbm.a.34731.
- Evaluation of microleakage of root canal fillings irradiated with different output powers of erbium, chromium:yttrium-scandium-gallium-garnet laser. Özer SY, Basaran E. Aust Endod J. 2013 Apr;39(1):8-14. doi: 10.1111/j.1747-4477.2009.00218.x.
- Gastroduodenal ulceration following liver radioembolization with yttrium-90. Veloso N, Brandão C, Gonçalves B, Costa L, Coimbra N, Jacome M, Moreira Dias L. Endoscopy. 2013;45 Suppl 2 UCTN:E108-9. doi: 10.1055/s-0032-1326346.
- Radioactive synovectomy with 90 yttrium and 153 samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety. Thomas S, Mendes JD, Souza SA, Lorenzato CS, Assi PE, Pacheco LR, Gabriel MB, Bordim A, Gutfilen B, da Fonseca LM. Haemophilia. 2013 Mar 28. doi: 10.1111/hae.12122.
- Phase I Study of a Modified Regimen of 90Yttrium-Ibritumomab Tiuxetan for Relapsed or Refractory Follicular or Transformed CD20+ Non-Hodgkin Lymphoma. Vaklavas C, Meredith RF, Shen S, Knox SJ, Micallef IN, Shah JJ, Lobuglio AF, Forero-Torres A. Cancer Biother Radiopharm.
- Radiosynoviorthesis in hemophilic joints with yttrium-90 citrate and rhenium-186 sulfide and long term results. Teyssler P, Taborska K, Kolostova K, Bobek V. Hell J Nucl Med. 2013 Jan-Apr;16(1):44-9. doi: 10.1967/s002449910071.
Proud Sponsors of the 10th Annual World Congress on Industrial
Biotechnology. Please join us and our customers & co-sponsors
Chevron and DuPont on June 16, 2013 in Montreal, Canada.

